UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis

Journal of leukocyte biology, 2013-11, Vol.94 (5), p.1079-1089

2013

Volltextzugriff (PDF)

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

Neurobiology of disease, 2015, Vol.73, p.254-268

2015

Volltextzugriff (PDF)

CXCL13 antibody for the treatment of autoimmune disorders

BMC immunology, 2015-02, Vol.16 (1), p.6-6, Article 6

2015

Volltextzugriff (PDF)

Generation and preclinical characterization of an antibody specific for SEMA4D

mAbs, 2016-01, Vol.8 (1), p.150-162

2016

Volltextzugriff (PDF)

Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements

Journal of Virology, 1999-04, Vol.73 (4), p.2832-2840

1999

Volltextzugriff (PDF)

Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction

Clinical immunology (Orlando, Fla.), 2016-03, Vol.164, p.85-94

2016

Volltextzugriff (PDF)

Abstract 4888: Antibody blockade of semaphorin 4D breaks down stromal barriers to enhance tumoricidal immune infiltration, supporting rational immunotherapy combinations

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4888-4888

2016

Volltextzugriff (PDF)

Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and inhibits tumor growth. (TUM7P.1030)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.142-142.19

2015

Volltextzugriff (PDF)

Development of anti-CXCL13 monoclonal antibody for the treatment of autoimmune and immuno-oncological disorders (THER2P.950)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.67-67.1

2015

Volltextzugriff (PDF)

Mutation of the Methylated tRNA3Lys Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Journal of virology, 2001-10, Vol.75 (20), p.9671-9678

2001

Volltextzugriff (PDF)

Abstract B023: Antibody blockade of Semaphorin 4D enhances infiltration of APC and CD8 T cells and reduces immune suppression to facilitate immune-mediated tumor rejection

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.B023-B023

2016

Volltextzugriff (PDF)

Abstract A119: Antibody blockade of Semaphorin 4D neutralizes barrier to immune infiltration and facilitates immune-mediated tumor rejection

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.A119-A119

2016

Volltextzugriff (PDF)

Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P220-P220, Article P220

2015

Volltextzugriff (PDF)

Mutation of the Methylated tRNA Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Journal of Virology, 2001-10, Vol.75 (20), p.9671

2001

Volltextzugriff (PDF)

Defective Lentiviral Vectors Are Efficiently Trafficked by HIV-1 and Inhibit Its Replication

Molecular therapy, 2001-06, Vol.3 (6), p.928-939

2001

Volltextzugriff (PDF)

Lentivirus and foamy virus vectors: novel gene therapy tools

Expert opinion on biological therapy, 2001-01, Vol.1 (1), p.17-40

2001

Volltextzugriff (PDF)

Mutation of the Methylated tRNA\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \setlength{\oddsidemargin}{-69pt} \begin{document} \begin{equation}{\mathrm{_{3}^{Lys}}}\end{equation}\end{document} Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Journal of virology, 2001-10, Vol.75 (20), p.9671-9678

2001

Volltextzugriff (PDF)

Lentiviral vectors and gene therapy

Frontiers in bioscience, 1999, Vol.4 (1-3), p.d481

Klimatcheva, Ekaterina

1999

Volltextzugriff (PDF)

Inhibition of HIV Type 1 Infection with a RANTES-IgG 3 Fusion Protein

AIDS research and human retroviruses, 1998-12, Vol.14 (18), p.1617-1624

1998

Volltextzugriff (PDF)

Ion currents and proliferation in MCF-7 human breast cancer cells

Klimatcheva, Ekaterina E

1997

Volltextzugriff (PDF)

Generation and preclinical characterization of an antibody specific for SEMA4D

mAbs, 2016, Vol.8 (1), p.150-162

2016

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(21)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Animals
(7)
Humans
(7)
Mice
(6)
Female
(4)
Hiv-1 - Genetics
(4)
Immunology
(4)
Arthritis
(3)
Genetic Vectors
(3)
Lentivirus - Genetics
(3)
Male
(3)
Medicine, Research & Experimental
(3)
Mice, Inbred C57bl
(3)
Research & Experimental Medicine
(3)
Biotechnology & Applied Microbiology
(2)
Care And Treatment
(2)
Cd100
(2)
Cells, Cultured
(2)
Chemokine Cxcl13 - Immunology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

CXCL13 antibody for the treatment of autoimmune disorders

Generation and preclinical characterization of an antibody specific for SEMA4D

Lentivirus Vectors Using Human and Simian Immunodeficiency Virus Elements

Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction

Abstract 4888: Antibody blockade of semaphorin 4D breaks down stromal barriers to enhance tumoricidal immune infiltration, supporting rational immunotherapy combinations

Antibody blockade of semaphorin 4D promotes infiltration of activated tumor infiltrating leukocytes and inhibits tumor growth. (TUM7P.1030)

Development of anti-CXCL13 monoclonal antibody for the treatment of autoimmune and immuno-oncological disorders (THER2P.950)

Mutation of the Methylated tRNA3Lys Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Abstract B023: Antibody blockade of Semaphorin 4D enhances infiltration of APC and CD8 T cells and reduces immune suppression to facilitate immune-mediated tumor rejection

Abstract A119: Antibody blockade of Semaphorin 4D neutralizes barrier to immune infiltration and facilitates immune-mediated tumor rejection

Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations

Mutation of the Methylated tRNA Residue A58 Disrupts Reverse Transcription and Inhibits Replication of Human Immunodeficiency Virus Type 1

Defective Lentiviral Vectors Are Efficiently Trafficked by HIV-1 and Inhibit Its Replication

Lentivirus and foamy virus vectors: novel gene therapy tools

Lentiviral vectors and gene therapy

Inhibition of HIV Type 1 Infection with a RANTES-IgG 3 Fusion Protein

Ion currents and proliferation in MCF-7 human breast cancer cells

Generation and preclinical characterization of an antibody specific for SEMA4D

Suchergebnisse filtern